Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Active, Not Recruiting

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

NCT05043090

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site CABA, Argentina
  • Research Site Ciudad Autónoma Buenos Aires, Argentina
View all 137 locations
View Trial Details
Active, Not Recruiting

A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer

NCT05678010

Conditions
Metastatic Cancer, Metastatic Solid Tumor, Metastatic Tumor, +8 more
Locations
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States
  • Memorial Sloan Kettering Westchester (All Protocol Activities) Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
View Trial Details
Active, Not Recruiting

A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)

NCT05374512

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Grand Junction, Colorado, United States
View all 228 locations
View Trial Details
Active, Not Recruiting

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

NCT05462717

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +60 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • UCSF San Francisco, California, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses

NCT04960787

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +9 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • Epic Care-Dublin Dublin, California, United States
View all 266 locations
View Trial Details
Active, Not Recruiting

Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)

NCT05638295

Conditions
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +4 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 180 locations
View Trial Details
Active, Not Recruiting

Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Patients Who Achieved Durable Response to Anti-HER2 Treatment

NCT06663787

Conditions
Breast Cancer, Metastatic, Breast Diseases, Breast Neoplasms, +10 more
Locations
  • Natera San Carlos, Texas, United States
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • Nagoya City University Nagoya, Aichi-ken, Japan
  • The Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo, Japan
View Trial Details

Related conditions